보이지 않는 암을 빠르고 정확하게 발견할 수 있습니다.
Clinical Utility of Circulating Tumor DNA for Tumor Profiling and Monitoring in High-Grade Serous Ovarian Cancer
Performance of a tissue-agnostic approach based on whole-genome methylation and fragmentomics features for detecting minimal residual disease (MRD) in colorectal cancer (CRC) and its comparison with a clinically validated, tissue-informed
"Utilizing cfDNA Fragment Traits to Identify CHIP in Canonical and Non-Canonical Genes with Machine Learning"
Postoperative Minimal Residual Disease Detection Using Tumor-Informed Circulating Tumor DNA Analysis in Stage II-III Gastric Cancer
Preliminary Results of Perioperative Minimal Residual Disease Monitoring Using a Tumor-informed ctDNA Assay in Stage II-III Breast Cancer
